Frangula purshiana bark

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Frangula purshiana bark
Accession Number
DB15478
Type
Biotech
Groups
Approved, Experimental
Description
Not Available
Synonyms
  • Cascara sagrada
Over the Counter Products
NameDosageStrengthRouteLabellerMarketing StartMarketing End
Aromatic Cascara Sagrada CompoundLiquidOralD.C. Labs Limited1951-12-312003-07-11Canada
Biofant - 41mg/5mlLiquidOralLes Laboratoires Vachon Inc.1995-12-311997-08-08Canada
Cascara AromaticLiquidOralIngram And Bell Inc.1953-12-311999-08-05Canada
Cascara Aromatic Liq 250mgLiquidOralDawson Traders Ltd.1977-12-312006-03-22Canada
Cascara Aromatique ElixirLiquidOralLab Valmo EnregistrÉ, Division Of Technilab Inc.1983-12-311999-09-17Canada
Cascara Fluid ExtLiquidOralStanley Pharmaceuticals, A Division Of Vita Health Products Inc.1965-12-312000-07-27Canada
Cascara SagradaCapsuleOralSundown Vitamins2000-11-232002-08-09Canada
Cascara SagradaCapsuleOralNatural Factors Nutritional Products Ltd.1998-10-212008-07-17Canada
Cascara Sagrada 300mgCapsuleOralGeneral Nutrition Canada Inc.1999-03-292005-08-05Canada
Cascara Sagrada 500mg - CapCapsuleOralHealth Wise Nutrition Inc.1997-08-151998-08-25Canada
Additional Data Available
  • Application Number
    Application Number

    A unique ID assigned by the FDA when a product is submitted for approval by the labeller.

    Learn more
  • Product Code
    Product Code

    A governmentally-recognized ID which uniquely identifies the product within its regulatory market.

    Learn more
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing End
Aid-lax TabFrangula purshiana bark (30 mg) + Alloin (12 mg) + Phenolphthalein (100 mg) + Sodium taurocholate (60 mg)TabletOralNobel Pharm Enr.1989-12-311997-07-31Canada
AlsilineFrangula purshiana bark (30 mg) + Alloin (12 mg) + Phenolphthalein (100 mg) + Sodium taurocholate (60 mg)TabletOralAlsi Cie Ltee1978-12-311997-08-08Canada
Bicholate LilasFrangula purshiana bark (30 mg) + Aloe Vera Leaf (12 mg) + Bisacodyl (5 mg) + Sodium taurocholate (60 mg)TabletOralSabex Inc1998-10-282009-11-24Canada
Bicholate Lilas TabFrangula purshiana bark (30 mg) + Alloin (12 mg) + Phenolphthalein (100 mg) + Sodium taurocholate (60 mg)TabletOralSabex Inc1991-12-311997-10-10Canada
Bilex TabFrangula purshiana bark (30 mg) + Alloin (12 mg) + Phenolphthalein (100 mg) + Sodium taurocholate (60 mg)TabletOralBiodo Enrg1978-12-311997-10-10Canada
C Ottways Lax TabFrangula purshiana bark (28 mg) + Aloe Vera Leaf (132 mg) + Capsicum (19 mg) + Ginger (9 mg) + Glycyrrhiza glabra (28 mg) + Sennosides (28 mg)TabletOralC Ottway Herbalist1950-12-311997-06-13Canada
CholasynFrangula purshiana bark (50 mg) + Sennosides (12 mg)TabletOralRolmex International Inc.1998-06-292001-08-14Canada
Cholasyn IIFrangula purshiana bark (175 mg) + Sennosides (25 mg)TabletOralRolmex International Inc.1983-12-312008-02-13Canada
Doulax TabFrangula purshiana bark (32.4 mg) + Phenolphthalein (97.2 mg)TabletOralLes Laboratoires Bio SantÉ Inc.1983-12-311998-01-14Canada
GeribileFrangula purshiana bark (600 mg) + Sennosides (25 mg)TabletOralLes Produits Gerbex Inc.1999-02-232005-06-29Canada
Categories
UNII
4VBP01X99F
CAS number
8015-89-2

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Additional Data Available
Adverse Effects

Comprehensive structured data on known drug adverse effects with statistical prevalence. MedDRA and ICD10 ids are provided for adverse effect conditions and symptoms.

Learn more
Additional Data Available
Contraindications

Structured data covering drug contraindications. Each contraindication describes a scenario in which the drug is not to be used. Includes restrictions on co-administration, contraindicated populations, and more.

Learn more
Additional Data Available
Blackbox Warnings

Structured data representing warnings from the black box section of drug labels. These warnings cover important and dangerous risks, contraindications, or adverse effects.

Learn more
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of adverse effects can be increased when Acetazolamide is combined with Frangula purshiana bark.
AclidiniumThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Aclidinium.
AgmatineThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Agmatine.
AlcuroniumThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Alcuronium.
AlfentanilThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Alfentanil.
AlphacetylmethadolThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Alphacetylmethadol.
AlphaprodineThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Alphaprodine.
AmantadineThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Amantadine.
AmilorideThe risk or severity of adverse effects can be increased when Amiloride is combined with Frangula purshiana bark.
AmiodaroneThe therapeutic efficacy of Frangula purshiana bark can be decreased when used in combination with Amiodarone.
Additional Data Available
  • Extended Description
    Extended Description

    Extended description of the mechanism of action and particular properties of each drug interaction.

    Learn more
  • Severity
    Severity

    A severity rating for each drug interaction, from minor to major.

    Learn more
  • Evidence Level
    Evidence Level

    A rating for the strength of the evidence supporting each drug interaction.

    Learn more
  • Action
    Action

    An effect category for each drug interaction. Know how this interaction affects the subject drug.

    Learn more
Food Interactions
Not Available

References

General References
Not Available
External Links
RxNav
1350209

Clinical Trials

Clinical Trials
Not Available

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
FormRouteStrength
PowderNot applicable1 kg/1kg
CapsuleOral
TabletOral
LiquidOral
KitOral
LiquidOral
TabletOral
CapsuleOral
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available

Taxonomy

Classification
Not classified

Drug created on August 30, 2019 09:40 / Updated on June 13, 2020 10:24

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Logo pink
Stay in the know!
As part of our commitment to providing the most up-to-date drug information, we will be releasing #DrugBankUpdates with our newly added curated drug pages.
#DrugBankUpdates